ITMI971329A0 - - Google Patents

Info

Publication number
ITMI971329A0
ITMI971329A0 ITMI971329A ITMI971329A ITMI971329A0 IT MI971329 A0 ITMI971329 A0 IT MI971329A0 IT MI971329 A ITMI971329 A IT MI971329A IT MI971329 A ITMI971329 A IT MI971329A IT MI971329 A0 ITMI971329 A0 IT MI971329A0
Authority
IT
Italy
Application number
ITMI971329A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI971329A0 publication Critical patent/ITMI971329A0/it
Priority to IT97MI001329A priority Critical patent/IT1292092B1/it
Priority to DE69822153T priority patent/DE69822153T2/de
Priority to AU86255/98A priority patent/AU8625598A/en
Priority to AT98937464T priority patent/ATE260655T1/de
Priority to PCT/EP1998/003497 priority patent/WO1998055118A2/en
Priority to DK98937464T priority patent/DK0986386T3/da
Priority to EP98937464A priority patent/EP0986386B1/en
Priority to JP50160699A priority patent/JP2002502410A/ja
Priority to US09/445,219 priority patent/US6323230B1/en
Priority to ES98937464T priority patent/ES2215315T3/es
Priority to PT98937464T priority patent/PT986386E/pt
Priority to CA002294547A priority patent/CA2294547A1/en
Publication of ITMI971329A1 publication Critical patent/ITMI971329A1/it
Application granted granted Critical
Publication of IT1292092B1 publication Critical patent/IT1292092B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT97MI001329A 1997-06-05 1997-06-05 Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali IT1292092B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT97MI001329A IT1292092B1 (it) 1997-06-05 1997-06-05 Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
EP98937464A EP0986386B1 (en) 1997-06-05 1998-06-04 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
US09/445,219 US6323230B1 (en) 1997-06-05 1998-06-04 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
AT98937464T ATE260655T1 (de) 1997-06-05 1998-06-04 Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
PCT/EP1998/003497 WO1998055118A2 (en) 1997-06-05 1998-06-04 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
DK98937464T DK0986386T3 (da) 1997-06-05 1998-06-04 Anvendelse af nitrogenheterocycliske, aromatiske derivater til topisk behandling af sygdomme i epitelvævene
DE69822153T DE69822153T2 (de) 1997-06-05 1998-06-04 Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
JP50160699A JP2002502410A (ja) 1997-06-05 1998-06-04 上皮組織疾患の局所治療における窒素複素環式芳香族誘導体の使用
AU86255/98A AU8625598A (en) 1997-06-05 1998-06-04 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
ES98937464T ES2215315T3 (es) 1997-06-05 1998-06-04 Uso de derivados aromaticos heterociclicos conteniendo nitrogeno en el tratamiento topico de las enfermedades de los tejidos epiteliales.
PT98937464T PT986386E (pt) 1997-06-05 1998-06-04 Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
CA002294547A CA2294547A1 (en) 1997-06-05 1998-06-04 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001329A IT1292092B1 (it) 1997-06-05 1997-06-05 Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali

Publications (3)

Publication Number Publication Date
ITMI971329A0 true ITMI971329A0 (US06559137-20030506-C00071.png) 1997-06-05
ITMI971329A1 ITMI971329A1 (it) 1998-12-05
IT1292092B1 IT1292092B1 (it) 1999-01-25

Family

ID=11377302

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001329A IT1292092B1 (it) 1997-06-05 1997-06-05 Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali

Country Status (12)

Country Link
US (1) US6323230B1 (US06559137-20030506-C00071.png)
EP (1) EP0986386B1 (US06559137-20030506-C00071.png)
JP (1) JP2002502410A (US06559137-20030506-C00071.png)
AT (1) ATE260655T1 (US06559137-20030506-C00071.png)
AU (1) AU8625598A (US06559137-20030506-C00071.png)
CA (1) CA2294547A1 (US06559137-20030506-C00071.png)
DE (1) DE69822153T2 (US06559137-20030506-C00071.png)
DK (1) DK0986386T3 (US06559137-20030506-C00071.png)
ES (1) ES2215315T3 (US06559137-20030506-C00071.png)
IT (1) IT1292092B1 (US06559137-20030506-C00071.png)
PT (1) PT986386E (US06559137-20030506-C00071.png)
WO (1) WO1998055118A2 (US06559137-20030506-C00071.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
CA2431326A1 (en) 2000-12-13 2002-06-20 Bayer Aktiengesellschaft Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors
WO2003014115A1 (en) * 2001-08-06 2003-02-20 Bayer Aktiengesellschaft 3-substituted pyrrolo (2.1-a) isoquinoline derivatives
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
CA2595075A1 (en) * 2005-01-12 2006-07-20 Matthias Vennemann Pyrrolodihydroisoquinolines as antiproliferative agents
PL2089367T3 (pl) 2006-10-31 2012-04-30 Pfizer Prod Inc Związki pirazolinowe jako antagoniści receptora mineralokortykoidowego
SI2155258T1 (sl) 2007-05-22 2017-10-30 Wyeth Llc Izboljšani postopki za izdelavo hidrazidov
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
CN116514801A (zh) * 2022-01-20 2023-08-01 四川大学 2-苯基-[1,2,4]三唑并[1,5-a]吡啶类化合物、其氮氧化物及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579352A (en) * 1977-05-06 1980-11-19 Lepetit Spa 3,5-disubstituted-1h-1,2,4-triazoles
FI64151C (fi) 1978-10-30 1983-10-10 Lepetit Spa Nya vid foedelsekontroll av daeggdjur anvaendbara 1h-1,2,4-triatzolderivat
DE2961326D1 (en) 1978-10-30 1982-01-14 Lepetit Spa New 1,2,4-triazole derivatives, a process for their manufacture and pharmaceutical compositions containing them
US4379155A (en) 1979-06-11 1983-04-05 Gruppo Lepetit S.P.A. 3,5-Disubstituted-1H-1,2,4-triazole derivatives
AU557034B2 (en) * 1981-10-20 1986-12-04 Gruppo Lepetit S.P.A. 3,5-diphenyl-1h-1,2,4-trazoles with contragestational
SE9300127L (sv) 1993-01-19 1994-07-20 Eyvind Langvad Tricyliska kondenserade 1,2,4-triazoloderivat användbara såsom antiinflammatoriska medel
DE4320801A1 (de) * 1993-06-23 1995-01-05 Fahlberg List Pharma Gmbh 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel
WO1995013268A1 (en) * 1993-11-12 1995-05-18 Gyógyszerkutató Intézet Kft. Ulcer-inhibiting triazole derivatives, pharmaceutical compositions containing them and process for preparing same

Also Published As

Publication number Publication date
DK0986386T3 (da) 2004-07-12
WO1998055118A2 (en) 1998-12-10
ATE260655T1 (de) 2004-03-15
DE69822153T2 (de) 2005-01-27
IT1292092B1 (it) 1999-01-25
WO1998055118A3 (en) 1999-04-15
ITMI971329A1 (it) 1998-12-05
DE69822153D1 (de) 2004-04-08
CA2294547A1 (en) 1998-12-10
PT986386E (pt) 2004-07-30
EP0986386B1 (en) 2004-03-03
EP0986386A2 (en) 2000-03-22
JP2002502410A (ja) 2002-01-22
ES2215315T3 (es) 2004-10-01
AU8625598A (en) 1998-12-21
US6323230B1 (en) 2001-11-27

Similar Documents

Publication Publication Date Title
ITTO970518A0 (US06559137-20030506-C00071.png)
CH0944937H2 (US06559137-20030506-C00071.png)
ITTO970345A0 (US06559137-20030506-C00071.png)
ITMI971064A0 (US06559137-20030506-C00071.png)
IN188731B (US06559137-20030506-C00071.png)
ITMI970413V0 (US06559137-20030506-C00071.png)
ITCA970013A0 (US06559137-20030506-C00071.png)
ITMI971308A0 (US06559137-20030506-C00071.png)
ITTO970577A0 (US06559137-20030506-C00071.png)
ITRM970334A0 (US06559137-20030506-C00071.png)
IN188541B (US06559137-20030506-C00071.png)
BR9700653A (US06559137-20030506-C00071.png)
BR9701757A (US06559137-20030506-C00071.png)
BY4238C1 (US06559137-20030506-C00071.png)
CN3058923S (US06559137-20030506-C00071.png)
CN3055519S (US06559137-20030506-C00071.png)
CN3055389S (US06559137-20030506-C00071.png)
BY4349C1 (US06559137-20030506-C00071.png)
CN3055179S (US06559137-20030506-C00071.png)
CN3055123S (US06559137-20030506-C00071.png)
CN3053170S (US06559137-20030506-C00071.png)
CN3056418S (US06559137-20030506-C00071.png)
CN3053500S (US06559137-20030506-C00071.png)
CN3054902S (US06559137-20030506-C00071.png)
CN3055603S (US06559137-20030506-C00071.png)

Legal Events

Date Code Title Description
0001 Granted